Immune-Mediated Colitis Induced by Immune Checkpoint Inhibitors: Pathophysiology, Clinical Management, and the Emerging Role of Fecal Microbiota Transplantation
Background/Objectives: Immune checkpoint inhibitors (ICIs) have revolutionized the treatment of various malignancies, but their use is frequently accompanied by immune-related adverse events, among which immune-mediated colitis (IMC) represents one of the most common and clinically significant gastr...
Sparad:
| Huvudupphov: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Utgiven: |
MDPI AG
2026-03-01
|
| Serie: | Biomedicines |
| Ämnen: | |
| Länkar: | https://www.mdpi.com/2227-9059/14/3/683 |
| Taggar: |
Inga taggar, Lägg till första taggen!
|
